4-Methoxyphenyl beta-D-glucopyranosideCAS# 6032-32-2 |
- 4-Methoxyphenyl-beta-galactoside
Catalog No.:BCX1609
CAS No.:3150-20-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 6032-32-2 | SDF | Download SDF |
PubChem ID | 80131 | Appearance | Powder |
Formula | C13H18O7 | M.Wt | 286.28 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-methoxyphenoxy)oxane-3,4,5-triol | ||
SMILES | COC1=CC=C(C=C1)OC2C(C(C(C(O2)CO)O)O)O | ||
Standard InChIKey | SIXFVXJMCGPTRB-UJPOAAIJSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
4-Methoxyphenyl beta-D-glucopyranoside Dilution Calculator
4-Methoxyphenyl beta-D-glucopyranoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4931 mL | 17.4654 mL | 34.9308 mL | 69.8617 mL | 87.3271 mL |
5 mM | 0.6986 mL | 3.4931 mL | 6.9862 mL | 13.9723 mL | 17.4654 mL |
10 mM | 0.3493 mL | 1.7465 mL | 3.4931 mL | 6.9862 mL | 8.7327 mL |
50 mM | 0.0699 mL | 0.3493 mL | 0.6986 mL | 1.3972 mL | 1.7465 mL |
100 mM | 0.0349 mL | 0.1747 mL | 0.3493 mL | 0.6986 mL | 0.8733 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- NBI 35965 hydrochloride
Catalog No.:BCC7567
CAS No.:603151-83-3
- Geissoschizine methyl ether
Catalog No.:BCN7736
CAS No.:60314-89-8
- Odanacatib (MK-0822)
Catalog No.:BCC1197
CAS No.:603139-19-1
- Sulforhodamine 101
Catalog No.:BCC8019
CAS No.:60311-02-6
- Tamarixetin
Catalog No.:BCN4116
CAS No.:603-61-2
- Chrysosplenetin
Catalog No.:BCN4115
CAS No.:603-56-5
- Auriculasin
Catalog No.:BCN3970
CAS No.:60297-37-2
- Fulvine
Catalog No.:BCN2082
CAS No.:6029-87-4
- Latifoline
Catalog No.:BCN1978
CAS No.:6029-86-3
- Rinderine
Catalog No.:BCN1971
CAS No.:6029-84-1
- 7-Angeloylretronecine
Catalog No.:BCN2036
CAS No.:6029-82-9
- Gestodene
Catalog No.:BCC4490
CAS No.:60282-87-3
- Sulprostone
Catalog No.:BCC7547
CAS No.:60325-46-4
- GSK-3 inhibitor 1
Catalog No.:BCC4126
CAS No.:603272-51-1
- LY2090314
Catalog No.:BCC1717
CAS No.:603288-22-8
- 9-O-Feruloyllariciresinol
Catalog No.:BCN4112
CAS No.:60337-67-9
- Leucovorin Calcium
Catalog No.:BCC1198
CAS No.:6035-45-6
- 6,7,8-Trimethoxycoumarin
Catalog No.:BCN4113
CAS No.:6035-49-0
- Doronine
Catalog No.:BCN2106
CAS No.:60367-00-2
- 7,8-Benzoflavone
Catalog No.:BCN6538
CAS No.:604-59-1
- Narcissoside
Catalog No.:BCN1263
CAS No.:604-80-8
- Tombozine
Catalog No.:BCN4117
CAS No.:604-99-9
- Cucurbitacin A
Catalog No.:BCN2468
CAS No.:6040-19-3
- Neopetasitenine
Catalog No.:BCN2114
CAS No.:60409-51-0
Translationally related nearly identical molecules: 4-methoxyphenyl 4-O-[6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-(fluoren-9-ylmethoxycarbonyl)-alph a-D-glucopyranosyl]-2-O-benzoyl-3-O-benzyl-6-O-chloroacetyl-beta-D-glucopyranosid e.[Pubmed:23744395]
Acta Crystallogr C. 2013 Jun;69(Pt 6):679-82.
The title compound, C59H56ClN3O16, is an important dissacharide precursor to novel therapeutics for the treatment of Alzheimer's disease. It crystallizes with two independent enantiomerically identical molecules in almost exactly the same orientation in the cell, being one half cell-edge apart. Apart from the conformation of a single benzyl group, the molecules are superimposable. They are bound efficiently using complementary C-H...O(carbonyl) hydrogen bonds, principally along the `duplicating' axis. The absolute configurations were determined.